SARS-CoV-2 mRNA Vaccine Development Enabled by Prototype Pathogen Preparedness | bioRxiv
A Single Immunization with Nucleoside-Modified mRNA Vaccines Elicits Strong Cellular and Humoral Immune Responses against SARS-C
mRNA vaccines — a new era in vaccinology | Nature Reviews Drug Discovery
Moderna's coronavirus vaccine shows encouraging early results - The Washington Post
A Single Immunization with Nucleoside-Modified mRNA Vaccines Elicits Strong Cellular and Humoral Immune Responses against SARS-C
SARS-CoV-2 mRNA Vaccine Development Enabled by Prototype Pathogen Preparedness | bioRxiv
FDA approves potential COVID-19 vaccine by Moderna for second-stage study - UPI.com
Delivering the Messenger: Advances in Technologies for Therapeutic mRNA Delivery - ScienceDirect
Frontiers | Current Efforts in the Development of Vaccines for the Prevention of Zika and Chikungunya Virus Infections | Immunology
SARS-CoV-2 mRNA Vaccine Development Enabled by Prototype Pathogen Preparedness | bioRxiv
A Single Immunization with Nucleoside-Modified mRNA Vaccines Elicits Strong Cellular and Humoral Immune Responses against SARS-CoV-2 in Mice. - Abstract - Europe PMC
PDF) Modified mRNA Vaccines Protect against Zika Virus Infection
mRNA vaccines - a new era in vaccinology. - Abstract - Europe PMC
mRNA vaccines - a new era in vaccinology. - Abstract - Europe PMC
Crowd fund launched for 'Battlestar Galactica' actor Michael Hogan after brain injury
SARS-CoV-2 mRNA Vaccine Development Enabled by Prototype Pathogen Preparedness | bioRxiv
Moderna Therapeutics — Wikipédia
SARS-CoV-2 mRNA Vaccine Development Enabled by Prototype Pathogen Preparedness | bioRxiv
Moderna's coronavirus vaccine trial is fully enrolled, 37 percent of participants are minorities - The Washington Post
Towards effective COVID‑19 vaccines: Updates, perspectives and challenges (Review)
mRNA vaccines - a new era in vaccinology. - Abstract - Europe PMC
Delivering the Messenger: Advances in Technologies for Therapeutic mRNA Delivery - ScienceDirect
Moncef Slaoui - Wikipedia
